Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0484-2026Class II

BD Kiestra" Isolate Suspension Cuvette Array; Catalog No.: 246100

Becton Dickinson & Co / initiated 2025-10-23 / Open, Classified / root cause: labeling and UDI

Becton Dickinson & Co. began a recall of BD Kiestra" Isolate Suspension Cuvette Array; Catalog No.: 246100 on . FDA classified it as Class II and gives the reason as "The 2D barcodes on these cuvettes contain formatting errors that prevent the analyzing system from correctly reading the expiration date. As a result, the instrument enters an error state and the cuvettes cannot be used". As of , the recall status on record is Open, Classified, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-0484-2026
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Becton Dickinson & Co
Product
BD Kiestra" Isolate Suspension Cuvette Array; Catalog No.: 246100;
Product code
LIB Device, General Purpose, Microbiology, Diagnostic
Reason for recall
The 2D barcodes on these cuvettes contain formatting errors that prevent the analyzing system from correctly reading the expiration date. As a result, the instrument enters an error state and the cuvettes cannot be used.
Root cause tag
labeling and UDI
FDA root cause
Under Investigation by firm
Action
On October 23, 2025 URGENT: Medical Device Correction letters were sent to customers. Actions for Clinical Users: 1. Immediately inspect your inventory for the specific catalog and lot numbers listed to determine if the lot in your possession is impacted and immediately discard any remaining inventory of the affected product. 2. *Note: Lot LM245666 has undergone rework and will be used as replacement material for affected product. Reworked inventory from this lot can be identified using the indicators described in ATTACHMENT 1- How to Identify Affected vs Reworked Product. Action to be taken by customer 1. Ensure the contents of this notification are read and understood. 2. Share and post this customer letter within your facility network and forward to any customers to whom you may have distributed the product to ensure awareness. 3. Complete the attached Customer Response Form and return to the BD contact noted on the form whether or not you have any of the impacted material so that BD may acknowledge your receipt of this notification per FDA requirements.
Quantity in commerce
29,760 units
Distribution
Worldwide - US Nationwide distribution in the states of CO, CT, KY, NJ, TN, TX, UT and the countries of Belgium, Singapore, Taiwan, Germany, Switzerland.
Product codes and lots
Catalog No.: 246100; UDI-DI: 30382902461006; Lot Number: LM245590, LM245592, LM245593, LM245594, LM245666;

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0484-2026
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0484-2026Class IIOngoingVoluntary: Firm initiated